Abstract
Intro Lifetime stressors (e.g., poverty, violence, discrimination) have been linked to Multiple Sclerosis (MS) features; yet mechanistic pathways and relationships with cumulative disease severity remain nebulous. Further, protective factors like resilience, that may attenuate the effects of stressors on outcomes, are seldom evaluated.
Aim To deconstruct pathways between lifetime stressors and cumulative severity on MS outcomes, accounting for resilience.
Methods Adults with MS (N=924) participated in an online survey through the National MS Society listserv. Structural Equation Modeling was used to examine the direct and indirect effect of lifetime stressors (count/severity) on MS severity (self-reported disability, relapse burden, fatigue, pain intensity and interference), via resilience, mental health (anxiety and depression), sleep disturbance, and smoking.
Results The final analytic model had excellent fit (GFI=0.998). Lifetime stressors had a direct relationship with MS severity (β=0.27, p<.001). Resilience, mental health, sleep disturbance, and smoking significantly mediated the relationship between lifetime stressors and MS severity. The total effect of mediation was significant (β=0.45).
Conclusions This work provides foundational evidence to inform conceptualization of pathways by which stress could influence MS disease burden. Resilience may attenuate effects of stressors, while poor mental health, smoking, and sleep disturbances may exacerbate their impact. Parallel with usual care, these mediators could be targets for early multimodal therapies to improve disease course.
Highlights
Lifetime stressors directly and indirectly relate to MS severity.
Resilience, mental health, sleep, and smoking were mediators.
Resilience attenuated the effects of stressors on mental health, sleep, and smoking.
Multi-modal interventions are needed to help improve MS symptom severity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
C.S. Polick was supported by NIH/NINR grant #T32NR016914 Complexity: Innovations for Promoting Health and Safety, the Duke Clinical and Translational Science Institute (CTSI), and the Durham VA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of Duke University gave ethical approval of this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Denotes co-senior authorship
Funding: C.S. Polick was supported by NIH/NINR grant #T32NR016914 Complexity: Innovations for Promoting Health and Safety, the Duke Clinical and Translational Science Institute (CTSI), and the Durham VA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.
COI statement: The authors of this original work have no conflicts of interest.
Data Availability
Data in the present study are available upon reasonable request to the authors
